Clinical Trials Directory

Trials / Completed

CompletedNCT06031675

Mechanism for Exercise to Delay Cardiac Aging

The αKlotho Protein-mediated NLRP3/Caspase-1/GSDMD Pathway Counteracts Myocardial Stunning: a Novel Mechanism for Exercise to Delay Cardiac Aging

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Xiao-dong Zhuang · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this clinicaltrial is to assess and compare isokinetic performance, surface electromyography, laboratory parameters, and cardiorespiratory function both before and after engaging in vigorous intermittent lifestyle physical activity(VILPA) within a healthy population. The main question it aims to answer is: \[1\] Does VILPA yield effective outcomes? Throughout the course of the trial, participants will engage in a simulated regimen of vigorous intermittent lifestyle physical activity for a duration of 8 weeks. The efficacy of the exercise protocol will be quantified and evaluated through the utilization of a wearable device.

Conditions

Interventions

TypeNameDescription
OTHERVigorous intermittent lifestyle physical activityThe specific exercise regimen involves performing rope jumping activities three times a day, with each session aimed at surpassing the exercise threshold (not conducted in a continuous manner), where the heart rate should exceed 160 beats per minute. This routine will be undertaken five times a week, continuously for a span of 8 weeks.

Timeline

Start date
2023-05-12
Primary completion
2023-07-10
Completion
2023-09-01
First posted
2023-09-11
Last updated
2023-09-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06031675. Inclusion in this directory is not an endorsement.